What is Vitamin K1?
Vitamin K1, also known as phylloquinone, is the classical form of vitamin K sourced from green plants. It plays a central role in the activation of clotting factors necessary for proper blood coagulation.
Without vitamin K, normal blood clotting cannot function properly. The vitamin acts as a cofactor for the enzyme gamma-glutamyl carboxylase (GGCX), which catalyzes the carboxylation of glutamic acid residues on clotting factors II, VII, IX, and X—the prothrombin complex. This modification is essential for these proteins to bind calcium and phospholipids, enabling the cascade of reactions that lead to stable blood clot formation.
What is Comparatively Well-Established?
Essential role in blood clotting: Vitamin K1’s function in blood coagulation is one of the most clearly established facts in nutrition science. This is why vitamin K deficiency can lead to serious bleeding disorders, particularly in newborns (hemorrhagic disease of the newborn, HDNB) and in patients with liver disease.
Relevance for bone metabolism: Beyond clotting, vitamin K is also a cofactor for bone Gla protein (BGP, also called osteocalcin), which appears important for bone mineralization and strength. Population studies suggest that adequate vitamin K intake correlates with higher bone mineral density, though the causal effect size remains moderate.
Undernutrition is clinically relevant: While severe vitamin K deficiency is rare in adults eating a typical diet, suboptimal intake does occur—particularly in populations with very low vegetable consumption or in patients on prolonged antibiotic therapy (which disrupts intestinal bacteria producing K2).
What is Less Well-Established?
Spectacular “healthy aging” effects from K1 supplements: Despite the biological plausibility of K1’s role in bone health and vascular calcification, large randomized controlled trials showing transformative effects on fracture prevention or cardiovascular outcomes in healthy populations are limited. Many studies are observational.
Major additional benefit in people with already good vegetable intake: Leafy greens (kale, spinach, collards, broccoli) are rich sources of K1. For people consuming adequate vegetables, supplementation may provide only marginal benefit.
K1 vs. K2 debate: While K1 is well-studied for its clotting function, K2 (menaquinone, derived from fermented foods or bacterial synthesis) has gained attention for bone and vascular health. However, the evidence base for K2 is considerably weaker than for K1’s clotting role, and direct comparative studies are scarce.
Safety Profile
For most people, vitamin K1 in typical dietary or supplemental amounts is unproblematic. Vitamin K is fat-soluble and stored in the liver, but toxicity from high intakes is essentially unknown in humans. No upper intake limit has been established by major regulatory agencies.
Important caveats:
Vitamin K antagonists interaction: If you take anticoagulants like warfarin (Coumadin), phenprocoumon (Marcumar), or acenocoumarol, vitamin K status is clinically significant. These drugs work by inhibiting vitamin K-dependent carboxylation, thereby reducing clotting factor production. High vitamin K intake interferes with anticoagulation; conversely, too little vitamin K can increase bleeding risk.
The fluctuation problem: Research shows that inconsistent vitamin K intake is particularly problematic for anticoagulated patients. Stable, moderate intake—whether high or low—is much easier to manage than erratic intake that swings between very low and very high. If you’re on a vitamin K antagonist, consistency matters more than absolute amount.
Other medications: Some antibiotics may reduce intestinal K2 production, and certain anticonvulsants can impair vitamin K metabolism. If you take medications affecting intestinal health or liver function, discuss vitamin K status with your healthcare provider.
Clinical Contexts Where K1 Matters
Newborns: All newborns are given vitamin K prophylaxis (usually K1 or K2) within hours of birth to prevent HDNB, which can be life-threatening.
Liver disease: Patients with cirrhosis or cholestasis often have impaired vitamin K absorption and synthesis, necessitating monitoring or supplementation.
Antibiotic therapy: Prolonged broad-spectrum antibiotics can deplete intestinal bacteria that synthesize K2, potentially lowering overall vitamin K status.
Malabsorption disorders: Celiac disease, cystic fibrosis, inflammatory bowel disease, and other conditions affecting fat absorption can impair vitamin K uptake.
Adequacy and Sources
Dietary reference intakes (DRI) are 120 mcg/day for adult men and 90 mcg/day for adult women. A single serving of raw spinach or kale easily exceeds this. Even modest amounts of leafy greens, broccoli, Brussels sprouts, or cabbage provide adequate K1 for non-anticoagulated individuals.
Supplemental K1 doses in the range of 100–1,000 mcg/day are generally considered safe, but exceeding typical food intakes without medical indication is not evidence-based.
Bottom Line
Vitamin K1 is a critical foundational nutrient—not glamorous, but genuinely important for basic hemostasis. The evidence for its role in blood clotting is rock-solid. The evidence for major bone or cardiovascular benefits in healthy individuals with adequate vegetable intake is more modest.
For people with low green vegetable consumption, malabsorption, certain liver conditions, or prolonged antibiotic use, K1 supplementation may be warranted. For those on anticoagulants, careful management of vitamin K intake under medical supervision is essential.
For the general, healthy population eating vegetables regularly, supplementation is unlikely to yield substantial benefits beyond what diet provides.